RONALD DAVIS to Antineoplastic Agents
This is a "connection" page, showing publications RONALD DAVIS has written about Antineoplastic Agents.
Connection Strength
0.066
-
An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non-muscle-invasive bladder cancer: Interim results. Urol Oncol. 2018 10; 36(10):440-447.
Score: 0.066